Renal mass-forming granulomatous inflammation associated with immune checkpoint inhibitor therapy

Pathology. 2024 Apr;56(3):421-423. doi: 10.1016/j.pathol.2023.06.015. Epub 2023 Sep 1.

Authors

Darren Yee Shuen Chua¹, Chloe Shu Hui Ong², Benjamin Yen Seow Goh², Nicholas Jin Hong Tan³

Affiliations

¹ Department of Pathology, National University Hospital, National University Health System, Singapore.
² Department of Urology, National University Hospital, National University Health System, Singapore.
³ Department of Pathology, National University Hospital, National University Health System, Singapore. Electronic address: nicholas_jh_tan@nuhs.edu.sg.

PMID: 37716817
DOI: 10.1016/j.pathol.2023.06.015

No abstract available

Publication types

Letter

MeSH terms

Carcinoma, Renal Cell* / drug therapy
Humans
Immune Checkpoint Inhibitors
Inflammation / drug therapy
Melanoma* / drug therapy
Nivolumab / adverse effects

Substances

Immune Checkpoint Inhibitors
Nivolumab